Article
Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer
25 Aug 2022
Abstract excerpt
DNA germline genetic testing can identify individuals with cancer susceptibility. However, DNA sequencing alone is limited in its detection and classification of mRNA splicing variants, particularly those located far from coding sequences. Here we address the limitations of splicing variant identification and interpretation by pairing DNA and RNA sequencing and describe the mutational and splicing landscape in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
